KRW195,400.00
3.27% yesterday
Korea, Sep 27, 08:09 am CET
ISIN
KR7068270008
Symbol
068270
Index
Sector
Industry

Celltrion Stock price

KRW194,800.00
-5,700.00 2.84% 1M
+10,600.00 5.75% 6M
-6,700.00 3.33% YTD
+55,968.64 40.31% 1Y
-55,257.43 22.10% 3Y
+49,911.27 34.45% 5Y
+160,520.99 468.28% 10Y
Korea, Closing price Fri, Sep 27 2024
-7,200.00 3.56%
ISIN
KR7068270008
Symbol
068270
Index
Sector
Industry

Key metrics

Market capitalization KRW41.68t
Enterprise Value KRW42.97t
P/E (TTM) P/E ratio 98.36
EV/FCF (TTM) EV/FCF 215.00
EV/Sales (TTM) EV/Sales 16.11
P/S ratio (TTM) P/S ratio 15.63
P/B ratio (TTM) P/B ratio 2.47
Dividend yield 0.25%
Last dividend (FY22) KRW500.00
Revenue growth (TTM) Revenue growth 17.07%
Revenue (TTM) Revenue KRW2.67t
EBIT (operating result TTM) EBIT KRW373.93b
Free Cash Flow (TTM) Free Cash Flow KRW199.85b
Cash position KRW1.03t
EPS (TTM) EPS KRW2,053.60
P/E forward 80.53
P/S forward 11.61
EV/Sales forward 11.97
Show more

Is Celltrion a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Celltrion Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Celltrion forecast:

17x Buy
81%
3x Hold
14%
1x Sell
5%

Analyst Opinions

21 Analysts have issued a Celltrion forecast:

Buy
81%
Hold
14%
Sell
5%

Financial data from Celltrion

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
2,666,611 2,666,611
17% 17%
100%
- Direct Costs 1,645,147 1,645,147
28% 28%
62%
1,021,464 1,021,464
3% 3%
38%
- Selling and Administrative Expenses 72,524 72,524
284% 284%
3%
- Research and Development Expense 177,788 177,788
28% 28%
7%
771,152 771,152
14% 14%
29%
- Depreciation and Amortization 397,221 397,221
86% 86%
15%
EBIT (Operating Income) EBIT 373,930 373,930
45% 45%
14%
Net Profit 323,331 323,331
41% 41%
12%

In millions KRW.

Don't miss a Thing! We will send you all news about Celltrion directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Celltrion, Inc. engages in the development, manufacture and distribution of pharmaceuticals. It operates through the Biopharmaceuticals, Chemical Drugs and Others businesses. Its products include remsima and biosimilars. The company was founded on February 27, 1991 and is headquartered in Incheon, South Korea.

Head office South Korea
CEO Wu-Sung Ki
Employees 2,529
Founded 1991
Website www.celltrion.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today